Human Milk Oligosaccharides Market Size, Share, Development, Growth, and Demand Forecast to 2024

  • Publishing: June 2021
  • Report Code: CM11506
  • Available Format: PDF

Market Overview

Human milk oligosaccharides are unconjugated complex carbohydrates which are found abundantly in human milk. It is the third most abundant ingredient after fat and carbohydrates in breast milk. It functions as a probiotic helping to establish commensal bacteria. It also functions as anti-adhesives which help in preventing attaching of microbial pathogens to mucosal surfaces. It helps in lowering the risk of viral, bacterial and protozoan parasite infections.

The human milk oligosaccharides market is segmented on the basis of product type, application, and geography. Based on product type, the market is categorized into 2’-fucosyllactose, 3’-fucosyllactose (3’FL), 3’-sialyllactose (3’SL), 6’-sialyllactose (6’SL), lacto-n-tetraose (LNT), and lacto-n-neotetraose (LNnT), and others. The 2’- fucosyllactose product type is expected to hold the largest share in the market, owing to its anti-infective capacity. This can also be attributed to the fact that it has a positive impact on the nervous system and cognition, and also reduces the risk of inflammation in the babies.

Based on application, the human milk oligosaccharides market is classified into functional food and beverage, food supplements, infant formulas, and others. Among all these, infant formulas are anticipated to grow at the fastest rate during the forecast period. This is attributable to the health benefits associated with the infant formulas such as maintaining gut microbiota and inhibition of pathogen in infants.

Market Dynamics


The major factors driving the human milk oligosaccharides market growth are rising awareness regarding the health benefits, increasing application areas, and technological advancements. The changing lifestyle of the young generation as well as the ageing population is encouraging the people toward healthy lifestyle. In order to remain healthy, people are preferring supplements in their food to enhance their immunity for longer and healthy life. Also, people are preferring them for their infants due to its potential benefits such as boost immunity, good nutrition, feed good bacteria in the gut, and others. Hence, these properties of the product is increasing demand globally.


High cost of production is identified as a major restraint in the human milk oligosaccharides market. It cannot be synthesised directly through human milk because of low availability of donor group. Various manufacturers are working to develop the technologies to produce the product through synthetic and enzymatic methods. However, synthetic and enzymatic methods require high resources and capital in order to produce the final product, thus posing a main threat to the market growth.


Increasing focus on the development of cost effective production techniques has opened avenues for innovation in the human milk oligosaccharides area which is expected to create growth opportunities in the human milk oligosaccharides market for the industry players. This area has a lot of scope for improvement and innovation, as no such cost-effective technique is available in the market till date. Hence, the manufacturers can attain a competitive edge in the market through innovation and technological advancement.

Insights by Geography

Europe is anticipated to hold the largest share in the human milk oligosaccharides market during the forecast period, due to the increasing demand of infant formulas to boost their immunity. Along with that, the increasing demand of the product from functional food and beverage industry is also expected to propel the market growth. Also, APAC market is also expected to witness a good growth in the coming years, owing to the increasing demand to deal with rising issues related to chronic diseases.

Competitive Landscape

Some of the major players operating in the global human milk oligosaccharides market include Medolac Laboratories, ZuChem Inc., Elicityl SA, Glycom, Glycosyn LLC, Inbiose NV, Jennewein Biotechnologie GmbH, Dextra Group, GNUbiotics Sciences, DowDuPont Inc, and ProZyme Inc.

Place An Order
USD 4900 USD 6400 USD 8400
Customized Report Solution

Get a bespoke market intelligence solution

We are committed to ensuring the highest level of client satisfaction
Quality Acknowledgement
Quality Acknowledgement

Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you

Unmatched Standards
Unmatched Standards

Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights

Reach Us
Reach Us Whenever You Need Us

With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required

Data Security
Complete Data Security

We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws